Follikuláris limfóma: vizsgálatok itt: Izrael
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Haifa, Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00 - 1/2. fázisTaking peopleDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT07249905 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Tel Aviv
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - 3. fázisTaking peopleA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Ashdod, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00 - 3. fázisTaking peopleA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Ashdod, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00 - 2. fázisTaking peopleTrial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .
- Where
- Haifa, Jerusalem, Tel Aviv
- Életkor
- 18 év and over
- People
- 40
- Run by
- Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07191249 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Jerusalem, Petah Tikva, Tel Aviv
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759